Herbert J. Conrad - 17 Jun 2021 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
Director
Signature
/s/ Samuel B. Martin, attorney in fact for Herbert J. Conrad
Issuer symbol
CLDX
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 16:19:38 UTC
Previous filing
24 May 2021
Next filing
24 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Non-Qualified Stock Option (right to buy) Award $0 +12,000 $0.000000 12,000 17 Jun 2021 Common Stock 12,000 $28.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.